KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Total Debt (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Total Debt for 17 consecutive years, with $20.8 billion as the latest value for Q4 2025.

  • Quarterly Total Debt fell 3.7% to $20.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.8 billion through Dec 2025, down 3.7% year-over-year, with the annual reading at $20.8 billion for FY2025, 3.7% down from the prior year.
  • Total Debt hit $20.8 billion in Q4 2025 for Bausch Health Companies, down from $21.0 billion in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $23.7 billion in Q1 2021 to a low of $20.6 billion in Q2 2023.
  • Historically, Total Debt has averaged $21.9 billion across 5 years, with a median of $21.7 billion in 2024.
  • Biggest YoY gain for Total Debt was 7.81% in 2023; the steepest drop was 10.86% in 2023.
  • Year by year, Total Debt stood at $22.7 billion in 2021, then fell by 8.33% to $20.8 billion in 2022, then rose by 7.81% to $22.4 billion in 2023, then fell by 3.45% to $21.6 billion in 2024, then decreased by 3.7% to $20.8 billion in 2025.
  • Business Quant data shows Total Debt for BHC at $20.8 billion in Q4 2025, $21.0 billion in Q3 2025, and $21.7 billion in Q2 2025.